John Markels
Director/Board Member en SANGAMO THERAPEUTICS, INC. .
Fortuna: 21 764 $ al 31/03/2024
Perfil
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. He is also a Director at Arcturus Therapeutics, Inc., Arcturus Therapeutics Ltd., and Arcturus Therapeutics Holdings, Inc. Previously, he served as the President-Global Vaccines at Merck & Co., Inc. Dr. Markels holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2024 | 32 484 ( 0.02% ) | 21 764 $ | 31/03/2024 | |
| 15/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de John Markels
| Empresas | Cargo | Inicio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 11/02/2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 08/12/2022 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Antiguos cargos conocidos de John Markels.
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/03/2022 |
Formación de John Markels.
| University of California, Berkeley | Doctorate Degree |
| University of Delaware | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John Markels
